CohBar

11:15 AM - 11:30 AM (EDT), Wednesday, October 23, 2019 ・ 2nd Floor
CohBar (CWBR) is a clinical stage biotechnology company focused on the development of mitochondrial-based therapeutics for the treatment of age-related diseases and extending healthy lifespan.
Ticker:
CWBR
Exchange:
NASDAQ
Company Type:
Company Website:
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
2009
Main Therapeutic Focus:
Lead Product in Development:
CB4211
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
3